MEAGAN TITUS: Open Payments
NPI 1992437404 · CONCORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$242 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $268 · 2025 $242
Food & beverage: $242
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $82 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Merck Sharp & Dohme LLC | 1 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $14 |
| Stryker Corporation | 1 | $14 |
Products named: DUPIXENT, NUCALA, KEYTRUDA, VOQUEZNA, NEFFY, Ryaltris, AUDION ET DILATION SYSTEM.
Industry payments across NC — which companies pay providers there.
